These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22934777)

  • 21. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
    Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
    J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series.
    Fürst Z; Búzás B; Friedmann T; Schmidhammer H; Borsodi A
    Eur J Pharmacol; 1993 May; 236(2):209-15. PubMed ID: 8391457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology.
    Zádor F; Király K; Váradi A; Balogh M; Fehér Á; Kocsis D; Erdei AI; Lackó E; Zádori ZS; Hosztafi S; Noszál B; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2017 Aug; 809():111-121. PubMed ID: 28502630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-
    Zádor F; Mohammadzadeh A; Balogh M; Zádori ZS; Király K; Barsi S; Galambos AR; László SB; Hutka B; Váradi A; Hosztafi S; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32192229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
    Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
    Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors.
    Thompson CM; Wojno H; Greiner E; May EL; Rice KC; Selley DE
    J Pharmacol Exp Ther; 2004 Feb; 308(2):547-54. PubMed ID: 14600248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
    Chakrabarti S; Law PY; Loh HH
    J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
    Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
    Capasso A; Sorrentino L; Pinto A
    Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
    Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.
    Paronis CA; Woods JH
    Eur J Pharmacol; 1997 Oct; 337(1):27-34. PubMed ID: 9389377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens.
    Porreca F; LoPresti D; Ward SJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I.
    Burford NT; Tolbert LM; Sadee W
    Eur J Pharmacol; 1998 Jan; 342(1):123-6. PubMed ID: 9544801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.